Slide of the Month
Where to meet us
Our most recent publications
Wang T, McAuslane N, Liberti L, Leufkens H, Hövels A. Building synergy between regulatory and HTA agencies beyond processes and procedures—Can we effectively align the evidentiary requirements? A survey of stakeholder perceptions. Value Health. DOI: http://dx.doi.org/10.1016/j.jval.2017.11.003
Bujar M, McAuslane N, Walker S, Salek S. Evaluating quality of decision-making processes in medicines’ development, regulatory review, and health technology assessment: A systematic review of the literature. Front Pharmacol. 2017 Apr 10;8:189. doi: 0.3389/fphar.2017.00189.
Liberti L, Bujar M, Breckenridge A, Hoekman J, McAuslane N, Stolk P, Leufkens H. FDA facilitated regulatory pathways: visualizing their characteristics and authorisation timelines. Front Pharmacol. 2017 Apr 3;8:161. doi: 10.3389/fphar.2017.00161.